Erratum to: Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma

In the original publication of the article, the frequency of loss-of-function mutations in AXIN1, AXIN2 and APC was underestimated in Table 1. The correct frequencies of these mutations in HCC are 10.4, 3.3, and 1.4%, respectively (in the following page).
On page 421, in the section of ‘‘Aberrant activation of Wnt/b-catenin signaling during HCC’’, the sentence following ‘‘Missense, insertion, or partial deletions within CTNNB1 exon 3 lead to … stabilization of b-catenin in the cytoplasm’’ should be read as ‘‘Less frequently, loss-offunction mutation of AXIN1, AXIN2, or APC is found in 10.4, 3.3, and 1.4% of HCCs respectively…’’.